PIN32 - Budget Impact Evaluation Of A Vaccination With Campaign Program For Corporations Using Pneumococcal Conjugated Vaccine (Pcv) 13 Valent Versus Pneumococcal Polisaccharide Vaccine (Ppv) 23 With Paid Campaign For Older Adults

Autor: Fujii, R.K., Presa, J., Roberts, C.S., Gea, Y., Manfrin, D.F., Mould, J.
Zdroj: In Value in Health May 2013 16(3):A84-A84
Databáze: ScienceDirect
Externí odkaz: